High Prevalence but Insufficient Treatment of Iron-Deficiency Anemia in Patients with Inflammatory Bowel Disease: Results of a Population-Based Cohort

Table 3

Details on the 8 patients with persisting iron-deficiency anemia despite of treatment.

Type of IBD	Hb level (g/dL)	Way of iron administration	Duration of substitution (months)	Disease-specific treatment	Activity of IBD
Crohn’s disease	11.1	oral	>12	—	Remission
Crohn’s disease	10.7	Oral and i.v.	1–3	Prednisolone	Chronic active
Crohn’s disease	13.3; (transferrin saturation 9%)	oral	1–3	—	Remission
Crohn’s disease	7.4	oral	1–3	Methotrexate	Chronic active
Ulcerative colitis	8.4	oral	>12	Mesalamine, prednisolone	Chronic active
Crohn’s disease	9.7	i.v.	1–3	Methotrexate	Chronic active
Ulcerative colitis	9.4	oral	<1	Mesalamine, prednisolone	Remission
Ulcerative colitis	11.9	oral	1–3	Mesalamine	Remission